Ozempic OverviewSemaglutide (USAN; trade name Ozempic) is a pharmaceutical drug developed by Danish company Novo Nordisk. Originally developed for the treatment of type 2 diabetes in 2012, it was found in 2017 that it can be used for the treatment of obesity. The drug has been approved by the US Food and Drug Administration (FDA) in 2017, and by the European Commission, the Health Canada and the Japanese Ministry of Health, Labour and Welfare in 2018. ...
Read more Ozempic Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Semaglutide
Recent Ozempic Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 2mg/1.5ml (1.34mg/ml)
NDC Database Records for Ozempic: (2 results)Sorted by National Drug Code
- 0169-4132 Ozempic 1.34 mg/ml Subcutaneous Injection, Solution by Novo Nordisk
- 0169-4136 Ozempic 1.34 mg/ml Subcutaneous Injection, Solution by Novo Nordisk